找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Target miRNA; Methods and Protocol Marco F. Schmidt Book 2017 Springer Science+Business Media, LLC, part of Springer Nature 2017 drug

[復(fù)制鏈接]
查看: 46260|回復(fù): 57
樓主
發(fā)表于 2025-3-21 19:40:58 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Drug Target miRNA
副標題Methods and Protocol
編輯Marco F. Schmidt
視頻videohttp://file.papertrans.cn/284/283130/283130.mp4
概述Includes cutting-edge methods and protocols.Provides step-by-step detail essential for reproducible results.Contains key notes and implementation advice from the experts
叢書名稱Methods in Molecular Biology
圖書封面Titlebook: Drug Target miRNA; Methods and Protocol Marco F. Schmidt Book 2017 Springer Science+Business Media, LLC, part of Springer Nature 2017 drug
描述.This volume provides a concise and technical discussion of recently developed approaches to overcome challenges, such as pharmacodynamics and pharmacokinetics difficulties, in miRNA drug discovery. These strategies cover anti-sense agents targeting miRNA that are applied in advanced formulations or are chemically optimized to increase delivery; small molecule miRNA modulators to overcome anti-sense agents’ limitations; general enhancers of miRNA maturation; and Argonaute 2 protein and its pharmacokinetic parameters. Written in the highly successful .Methods in Molecular Biology .series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls..Cutting-edge and thorough, .Drug Target miRNA: Methods and Protocols. is a valuable resource for anyone interested in the ever-evolving field of miRNA drug discovery...?.
出版日期Book 2017
關(guān)鍵詞drug discovery; pharmacodynamics; pharmacokinetics; small molecule miRNA modulators; anti-sense agents; D
版次1
doihttps://doi.org/10.1007/978-1-4939-6563-2
isbn_softcover978-1-4939-8236-3
isbn_ebook978-1-4939-6563-2Series ISSN 1064-3745 Series E-ISSN 1940-6029
issn_series 1064-3745
copyrightSpringer Science+Business Media, LLC, part of Springer Nature 2017
The information of publication is updating

書目名稱Drug Target miRNA影響因子(影響力)




書目名稱Drug Target miRNA影響因子(影響力)學(xué)科排名




書目名稱Drug Target miRNA網(wǎng)絡(luò)公開度




書目名稱Drug Target miRNA網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Drug Target miRNA被引頻次




書目名稱Drug Target miRNA被引頻次學(xué)科排名




書目名稱Drug Target miRNA年度引用




書目名稱Drug Target miRNA年度引用學(xué)科排名




書目名稱Drug Target miRNA讀者反饋




書目名稱Drug Target miRNA讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:52:19 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:08:12 | 只看該作者
地板
發(fā)表于 2025-3-22 07:18:58 | 只看該作者
5#
發(fā)表于 2025-3-22 10:17:25 | 只看該作者
Ausblick: Eine Roadmap der FAS 2003 – 2006olecules targeting miRNAs is a useful technology platform for anticancer drug development. Here, we describe a hepatocellular carcinoma (HCC) cell-based luciferase reporter system which could be used to screen for small molecule modulators of tumor suppressor microRNA-34a.
6#
發(fā)表于 2025-3-22 15:11:24 | 只看該作者
Competitive Argonaute-Based RNA Immunoprecipitation for Investigation of Transcriptomic Response to elopmental therapeutics that modulate miRNAs, such as anti-miRNA oligonucleotides (anti-miR). Here, we describe a method that uses changes in Argonaute 2-RNA immunoprecipitation in response to competition by anti-miR, titrated ex vivo, as physical evidence for target validation.
7#
發(fā)表于 2025-3-22 19:53:36 | 只看該作者
8#
發(fā)表于 2025-3-22 21:15:16 | 只看該作者
9#
發(fā)表于 2025-3-23 02:08:41 | 只看該作者
10#
發(fā)表于 2025-3-23 09:27:21 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 22:01
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
阿鲁科尔沁旗| 临沂市| 都匀市| 莱阳市| 合川市| 望城县| 宜兰县| 深圳市| 东乡| 天长市| 万安县| 德安县| 隆回县| 长宁县| 静海县| 克山县| 额尔古纳市| 奉化市| 大连市| 微博| 彭阳县| 富民县| 汝南县| 桦甸市| 廊坊市| 泾川县| 阳江市| 阳原县| 安宁市| 廊坊市| 南昌县| 屏东县| 宿松县| 八宿县| 临颍县| 深圳市| 昌都县| 神木县| 兴化市| 阳朔县| 南部县|